Table 4 Effect of choline supplementation in different patient subgroups
From: Asthma in the elderly: the effect of choline supplementation
Baseline | 6 weeks | |
|---|---|---|
ACT ≤ 20 (Choline) | 16.7 ± 3.3 | 21.5 ± 3 |
ACT ≤ 20 (Placebo) | 22.3 ± 2.9 | |
FEV1 % < 60 % (Choline) | 46.4 ± 9.2 | 47 ± 10.3 |
FEV1 % < 60 % (Placebo) | 46.6 ± 6.8 | |
Eosinophils ≥ 0.6 K/µL (Choline) | 0.88 ± 0.35 | 0.62 ± 0.4 |
Eosinophils ≥ 0.6 K/µL (Placebo) | 0.62 ± 0.5 |